Astroglial Inhibition of NF-κB Does Not Ameliorate Disease Onset and Progression in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS). This evidence concerns the gene NFKB1 and amyotrophic lateral sclerosis.